Elevated serum levels of soluble ST2 in severe COVID-19: as a potential biomarker for invasive mechanical ventilation
H. Inoue (Tokyo, Japan), Y. Fukuda (Tokyo, Japan), S. Ohta (Tokyo, Japan), T. Homma (Tokyo, Japan), K. Mochizuki (Tokyo, Japan), H. Ikeda (Tokyo, Japan), T. Ebato (Tokyo, Japan), H. Mikuni (Tokyo, Japan), T. Okazaki (Tokyo, Japan), T. Uno (Tokyo, Japan), Y. Uchida (Tokyo, Japan), T. Kimura (Tokyo, Japan), Y. Miyata (Tokyo, Japan), K. Hirai (Tokyo, Japan), S. Kusumoto (Tokyo, Japan), S. Suzuki (Tokyo, Japan), A. Tanaka (Tokyo, Japan), H. Sagara (Tokyo, Japan)
Source: International Congress 2022 – COVID prognosis
Session: COVID prognosis
Session type: Thematic Poster
Number: 1844
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Inoue (Tokyo, Japan), Y. Fukuda (Tokyo, Japan), S. Ohta (Tokyo, Japan), T. Homma (Tokyo, Japan), K. Mochizuki (Tokyo, Japan), H. Ikeda (Tokyo, Japan), T. Ebato (Tokyo, Japan), H. Mikuni (Tokyo, Japan), T. Okazaki (Tokyo, Japan), T. Uno (Tokyo, Japan), Y. Uchida (Tokyo, Japan), T. Kimura (Tokyo, Japan), Y. Miyata (Tokyo, Japan), K. Hirai (Tokyo, Japan), S. Kusumoto (Tokyo, Japan), S. Suzuki (Tokyo, Japan), A. Tanaka (Tokyo, Japan), H. Sagara (Tokyo, Japan). Elevated serum levels of soluble ST2 in severe COVID-19: as a potential biomarker for invasive mechanical ventilation. 1844
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|